Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

What You Need To Know Ahead of Edwards Lifesciences' Earnings Release

With a market cap of $52.1 billion, Edwards Lifesciences Corporation (EW) is a global leader in structural heart innovation, dedicated to improving patient lives through breakthrough medical technologies and evidence-based solutions. Driven by a patient-focused culture and strong partnerships with clinicians and healthcare stakeholders, the company delivers life-changing innovations to people around the world.

The Irvine, California-based company is expected to unveil its fiscal Q2 2026 results soon. Ahead of the event, analysts forecast EW to post an adjusted EPS of $0.73, a growth of nearly 9% from $0.67 in the same quarter last year. It has surpassed Wall Street's bottom-line projections in three of the past four quarters while missing on another occasion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.